Ficha del valor · trimestre archivado
AVTX
Avalo Therapeutics, Inc. · Healthcare · Biotechnology
35Tenedores rastreados
+2Δ titulares
8.20MAcciones mantenidas
$148.88MValor declarado
+2Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +6.1% ·
flujo de acciones +26.7% ·
nuevas posiciones netas +5.7%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 51 | +13 | 31.74M | $586.58M | +19 | −6 |
| Q1 2026 | 38 | +3 | 12.35M | $184.22M | +7 | −4 |
| Q4 2025 | 35 | +2 | 8.20M | $148.88M | +2 | — |
| Q3 2025 | 13 | +7 | 3.14M | $39.85M | +7 | — |
| Q2 2025 | 4 | +1 | 446.19K | $2.23M | +1 | — |
| Q1 2025 | 1 | -1 | 107.81K | $864,389 | — | −1 |
| Q4 2024 | 2 | +1 | 120.18K | $892,907 | +1 | — |
| Q3 2024 | 1 | +1 | 10.11K | $95,649 | +1 | — |
Quién lo tiene en cartera · Q4 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 804.08K | +16.1% | $14.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasivo) | 804.08K | +16.1% | $14.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasivo) | 804.08K | +16.1% | $14.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 659.98K | +380.2% | $11.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 627.50K | -40.5% | $11.40M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Bank Of America Corp /De/ | 621.35K | — | $11.28M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Bank Of America Corp /De/ | 621.35K | — | $11.28M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 550.00K | +112.5% | $9.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 507.55K | +806.2% | $9.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 507.55K | +806.2% | $9.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 507.55K | +806.2% | $9.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | UBS Group AG | 477.82K | — | $8.68M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | UBS Group AG | 477.82K | — | $8.68M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | UBS Group AG | 477.82K | — | $8.68M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Jennison Associates Llc | 475.62K | — | $8.64M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Balyasny Asset Management L.P. | 439.31K | — | $7.98M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 419.49K | -12.9% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 419.49K | -12.9% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (pasivo) | 289.57K | +87.7% | $5.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | BlackRock ✦ (pasivo) | 289.57K | +87.7% | $5.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | BlackRock ✦ (pasivo) | 289.57K | +87.7% | $5.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | BlackRock ✦ (pasivo) | 289.57K | +87.7% | $5.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | BlackRock ✦ (pasivo) | 289.57K | +87.7% | $5.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | BlackRock ✦ (pasivo) | 289.57K | +87.7% | $5.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 264.91K | +2648970.0% | $4.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 264.91K | +2648970.0% | $4.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 264.91K | +2648970.0% | $4.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 264.91K | +2648970.0% | $4.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 220.30K | Nuevo | $4.00M | 0.0% | New | 1 | SEC ↗ |
| 30 | Ameriprise Financial Inc | 217.97K | — | $3.96M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Susquehanna International Group, Llp | 210.99K | — | $3.83M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Bnp Paribas Financial Markets | 197.75K | — | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Jane Street Group, Llc | 178.85K | — | $3.25M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Jane Street Group, Llc | 178.85K | — | $3.25M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Jane Street Group, Llc | 178.85K | — | $3.25M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Geode Capital Management ✦ (pasivo) | 166.15K | +59.5% | $3.02M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 37 | Geode Capital Management ✦ (pasivo) | 166.15K | +59.5% | $3.02M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | Deutsche Bank Ag\ | 150.00K | — | $2.72M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Two Sigma Investments ✦ | 148.24K | +201.0% | $2.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | Barclays Plc | 105.81K | — | $1.92M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Barclays Plc | 105.81K | — | $1.92M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Aberdeen Group plc | 95.43K | — | $1.73M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | State Street Global Advisors ✦ (pasivo) | 79.25K | +74.4% | $1.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 44 | Goldman Sachs Group ✦ | 65.31K | Nuevo | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 45 | Qube Research & Technologies Ltd | 64.46K | — | $1.17M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 44.43K | +1312.3% | $806,867 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 47 | Squarepoint Ops LLC | 40.85K | — | $741,909 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Northern Trust Corp | 32.20K | — | $584,825 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Renaissance Technologies ✦ | 18.30K | -81.5% | $332,328 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 50 | Envestnet Asset Management Inc | 16.04K | — | $291,268 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Belvedere Trading LLC | 4.53K | — | $82,192 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Us Bancorp \De\ | 2.73K | — | $49,631 | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Us Bancorp \De\ | 2.73K | — | $49,631 | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Citigroup Inc | 1.14K | — | $20,757 | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Group One Trading Llc | 1 | — | $18 | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Osaic Holdings, Inc. | 1 | — | $18 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Fidelity (FMR) | $4.00M | 0.0% |
| Goldman Sachs Group | $1.19M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 96 tenedores, 30.91M acciones, $428.51M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Aug 18
Sullivan Christopher Ryan
Officer · 31.03K acc. · $622,324
Aug 17
Sullivan Christopher Ryan
Officer · 37.95K acc. · $753,333
Aug 17
Sullivan Christopher Ryan
Officer · 3.75K acc. · $74,762
Aug 17
Doyle Mittie
Officer · 1.00K acc. · $20,000
Aug 11
Riley Jennifer
Officer · 2.65K acc. · $52,012
Aug 10
Doyle Mittie
Officer · 679 acc. · $13,580
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
Aug 14
SC 13G/A — T. Rowe Price Investment Management…
Aug 14
SC 13G/A — Caligan Partners LP
Aug 14
SC 13G/A — RA CAPITAL MANAGEMENT, L.P.
Aug 14
SC 13G/A — Deep Track Capital, LP
Aug 14
SC 13G/A — Nantahala Capital Management, LLC
Aug 14
SC 13G/A — BIOTECHNOLOGY VALUE FUND L P
Aug 14
SC 13G/A — Avoro Capital Advisors LLC
Aug 13
SC 13G/A — Affinity Asset Advisors, LLC
Aug 07
SC 13G/A — FMR LLC
Aug 07
SC 13G — STATE STREET CORP
Aug 06
SC 13G/A — FMR LLC
Jul 27
SC 13G — BlackRock, Inc.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q4 2025 ·
Metodología ·
Obtener esto a través de la API